Abstract
The purpose of this research was to develop a simple and convenient in vitro release method for biodegradable microspheres using a commercially available dialyzer. A 25 KD MWCO Float-a-Lyzer was used to evaluate peptide diffusion at 37°C and 55°C in different buffers and assess the effect of peptide concentration. In vitro release of Leuprolide from PLGA microspheres, having a 1-month duration of action, was assessed using the dialyzer and compared with the commonly used “sample and separate” method with and without agitation. Peptide diffusion through the dialysis membrane was rapid at 37°C and 55°C in all buffers and was independent of peptide concentration. There was no detectable binding to the membrane under the conditions of the study. In vitro release of Leuprolide from PLGA microspheres was tri-phasic and was complete in 28 days with the dialysis technique. With the sample and separate technique, linear release profiles were obtained with complete release occurring under conditions of agitation. Diffusion through the dialysis membrane was sufficiently rapid to qualify the Float-a-Lyzer for an in vitro release system for microparticulate dosage forms. Membrane characteristics render it useful to study drug release under real-time and accelerated conditions.
KeyWords: biodegradable microspheres, in vitro release methods, dialysis
Full Text
The Full Text of this article is available as a PDF (205.5 KB).
References
- 1.Anderson JM, Shive MS. Biodegradation and biocompatibility of PLA and PLGA microspheres. Adv Drug Deliv Rev. 1997;28:5–24. doi: 10.1016/S0169-409X(97)00048-3. [DOI] [PubMed] [Google Scholar]
- 2.Sinha VR, Trehan A. Biodegradable microspheres for protein delivery. J Control Release. 2003;90:261–280. doi: 10.1016/S0168-3659(03)00194-9. [DOI] [PubMed] [Google Scholar]
- 3.Zhou S, Liao X, Li X, Deng X, Li H. Poly-D,L-lactideco-poly(ethylene glycol) microspheres as potential vaccine delivery systems. J Control Release. 2003;86:195–205. doi: 10.1016/S0168-3659(02)00423-6. [DOI] [PubMed] [Google Scholar]
- 4.Wu L, Ding J. In vitro degradation of three-dimensional porous poly(D,L-lactide-co-glycolide) scaffolds for tissue engineering. Biomaterials. 2004;25:5821–5830. doi: 10.1016/j.biomaterials.2004.01.038. [DOI] [PubMed] [Google Scholar]
- 5.Middleton JC, Tipton AJ. Synthetic biodegradable polymers as orthopedic devices. Biomaterials. 2000;21:2335–2346. doi: 10.1016/S0142-9612(00)00101-0. [DOI] [PubMed] [Google Scholar]
- 6.Hickey T, Kreutzer D, Burgess DJ, Moussy F. Dexamethasone/PLGA microspheres for continuous delivery of an anti-inflammatory drug for implantable medical devices. Biomaterials. 2002;23:1649–1656. doi: 10.1016/S0142-9612(01)00291-5. [DOI] [PubMed] [Google Scholar]
- 7.Burgess DJ, Hickey AJ. Microsphere technology and applications. In: Swarbrick J, Boylan JC, editors. Encyclopedia of Pharmaceutical Technology. New York, NY: Marcel Dekker; 1994. pp. 1–29. [Google Scholar]
- 8.Burgess DJ, Hussain AS, Ingallinera TS, Chen ML. Assuring quality and performance of sustained and controlled release parenterals: workshop report. AAPS Pharm Sci. 2002;4(2):E7–E7. doi: 10.1208/ps040207. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Schaefer MJ, Singh J. Effect of tricaprin on the physical characteristics and in vitro release of etoposide from PLGA microspheres. Biomaterials. 2002;23:3465–3471. doi: 10.1016/S0142-9612(02)00053-4. [DOI] [PubMed] [Google Scholar]
- 10.Ruan G, Feng S-S, Li Q-T. Effects of material hydrophobicity on physical properties of polymeric microspheres formed by double emulsion process. J Control Release. 2002;84:151–160. doi: 10.1016/S0168-3659(02)00292-4. [DOI] [PubMed] [Google Scholar]
- 11.Ruan G, Feng S-S. Preparation and characterization of poly(lactic acid)-poly(ethylene glycol)-poly(lactic acid) (PLA-PEG-PLA) microspheres for controlled release of paclitaxel. Biomaterials. 2003;24:5037–5044. doi: 10.1016/S0142-9612(03)00419-8. [DOI] [PubMed] [Google Scholar]
- 12.Diwan M, Park TG. Stabilization of recombinant interferon-α by pegylation for encapsulation in PLGA microspheres. Int J Pharm. 2003;252:111–122. doi: 10.1016/S0378-5173(02)00636-1. [DOI] [PubMed] [Google Scholar]
- 13.Liu FI, Kuo JH, Sung KC, Hu OY. Biodegradable polymeric microspheres for nalbuphine prodrug controlled delivery: in vitro characterization and in vivo pharmacokinetic studies. Int J Pharm. 2003;257:23–31. doi: 10.1016/S0378-5173(03)00110-8. [DOI] [PubMed] [Google Scholar]
- 14.Poulain N, Dez I, Perrio C, Lasne MC, Prud’homme MP, Nakache E. Microspheres based on inulin for the controlled release of serine protease inhibitors: preparation, characterization and in vitro release. J Control Release. 2003;92:27–38. doi: 10.1016/S0168-3659(03)00251-7. [DOI] [PubMed] [Google Scholar]
- 15.Larsen DH, Fredholt K, Larsen C. Assessment of rate of drug release from oil vehicle using a rotating dialysis cell. Eur J Pharm Sci. 2000;11:223–229. doi: 10.1016/S0928-0987(00)00105-6. [DOI] [PubMed] [Google Scholar]
- 16.Park TG, Lu W, Crotts G. Importance of in vitro experimental conditions on protein release kinetics, stability and polymer degradation in protein encapsulated poly(D,L-lactic acid-co-glycolic acid) microspheres. J Control Release. 1995;33:211–222. doi: 10.1016/0168-3659(94)00084-8. [DOI] [Google Scholar]
- 17.Berthold A, Cremer K, Kreuter J. Preparation and characterization of chitosan microspheres as drug carrier for prednisolone sodium phosphate as model for anti-inflammatory drugs. J Control Release. 1996;39:17–25. doi: 10.1016/0168-3659(95)00129-8. [DOI] [Google Scholar]
- 18.Diaz RV, Llabres M, Evora C. One-month sustained release microspheres of 125I-bovine calcitonin: In vitro-in vivo studies. J Control Release. 1999;59:55–62. doi: 10.1016/S0168-3659(98)00179-5. [DOI] [PubMed] [Google Scholar]
- 19.Woo BH, Kostanski JW, Gebrekidan S, Dani BA, Thanoo BC, DeLuca PP. Preparation, characterization and in vivo evaluation of 120-day poly(-lactide) leuprolide microspheres. J Control Release. 2001;75:307–315. doi: 10.1016/S0168-3659(01)00403-5. [DOI] [PubMed] [Google Scholar]
- 20.Kostanski JW, DeLuca PP. A novel in vitro release technique for peptide-containing biodegradable microspheres. AAPS Pharm Sci Tech. 2000;1:E4–E4. doi: 10.1208/pt010104. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Shameem M, Heeyong L, DeLuca PP. A short-term (accelerated release) approach to evaluate peptide release from PLGA depot formulations. AAPS Pharm Sci. 1999;1:E7–E7. doi: 10.1208/ps010307. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Burgess DJ, Hussain AS, Ingallinera TS, Chen ML. Assuring quality and performance of sustained and controlled release parenterals: AAPS workshop report, co-sponsored by FDA and USP. Pharm Res. 2002;19:1761–1768. doi: 10.1023/A:1020730102176. [DOI] [PubMed] [Google Scholar]
- 23.Sturesson C, Artursson P, Ghaderi R, et al. Encapsulation of rotavirus into poly(lactide-co-glycolide) microspheres. J Control Release. 1999;59:377–389. doi: 10.1016/S0168-3659(99)00014-0. [DOI] [PubMed] [Google Scholar]
- 24.Özbas-Turan S, Akbuga J, Aral C. Controlled release of interleukin-2 from chitosan microspheres. J Pharm Sci. 2002;91:1245–1251. doi: 10.1002/jps.10122. [DOI] [PubMed] [Google Scholar]
- 25.Mi FL, Shyu SS, Lin YM, Wu YB, Peng CK, Tsai YH. Chitin/PLGA blend microspheres as a biodegradable drug delivery system: a new delivery system for protein. Biomaterials. 2003;24:5023–5036. doi: 10.1016/S0142-9612(03)00413-7. [DOI] [PubMed] [Google Scholar]
- 26.Constantino HR, Johnson OL, Zale SE. Relationship between encapsulated drug particle size and initial release of recombinant human growth hormone from biodegradable microspheres. J Pharm Sci. 2004;93:2624–2634. doi: 10.1002/jps.20078. [DOI] [PubMed] [Google Scholar]
- 27.Dasaratha Dhanaraju M, Vema K, Jayakumar R, Vamsadhara C. Preparation and characterization of injectable microspheres of contraceptive hormones. Int J Pharm. 2003;268:23–29. doi: 10.1016/j.ijpharm.2003.08.011. [DOI] [PubMed] [Google Scholar]
- 28.Shah VP, Gurbarg M, Noory A, Dighe S, Skelly JP. Influence of higher rates of agitation on release patterns of immediate-release drug products. J Pharm Sci. 1992;81:500–503. doi: 10.1002/jps.2600810604. [DOI] [PubMed] [Google Scholar]
- 29.Kamba M, Seta Y, Takeda N, et al. Measurement of agitation force in dissolution test and mechanical destructive force in disintegration test. Int J Pharm. 2003;250:99–109. doi: 10.1016/S0378-5173(02)00535-5. [DOI] [PubMed] [Google Scholar]
- 30.Costa P, Lobo JMS. Influence of dissolution medium agitation on release profiles of sustained-release tablets. Drug Dev Ind Pharm. 2001;27:811–817. doi: 10.1081/DDC-100107244. [DOI] [PubMed] [Google Scholar]
- 31.Shenderova A, Burke TG, Schwendeman SP. The acidic microclimate in poly(lactide-co-glycolide) microspheres stabilizes comptothecins. Pharm Res. 1999;16(2):241–248. doi: 10.1023/A:1018876308346. [DOI] [PubMed] [Google Scholar]
- 32.Mader K, Bittner B, Li Y, Wohlauf W, Kissel T. Monitoring microviscosity and microacidity of the albumin microenvironment inside degrading microparticles from poly(lactide-co-glycolide) (PLG) or ABA-triblock polymers containing hydrophilic poly(lactide-co-glycolide) A blocks and hydrophilic poly(ethylene) B blocks. Pharm Res. 1998;15:787–793. doi: 10.1023/A:1011939607573. [DOI] [PubMed] [Google Scholar]
- 33.Zhu G, Mallery SR, Schwendeman SP. Stabilization of proteins encapsulated in injectable poly(lactide-co-glycolide) Nat Biotechnol. 2000;18:52–57. doi: 10.1038/71916. [DOI] [PubMed] [Google Scholar]